Literature DB >> 23758337

A comparison of the efficacy of autologous serum eye drops with amniotic membrane transplantation in neurotrophic keratitis.

Elif Turkoglu1, Erkan Celik, Gursoy Alagoz.   

Abstract

PURPOSE: To investigate and compare the efficacy of autologous serum eye drops with amniotic membrane transplantation in eyes with neurotrophic corneal ulcers.
METHODS: In this retrospective study, 42 eyes of 42 patients (30 females and 12 males) with neurotrophic corneal ulcers were included and divided into group I (n = 20) who were treated with autologous serum eye drops and group II (n = 22) who underwent amniotic membrane transplantation. The epithelial healing time and best corrected visual acuity were performed before and after treatments.
RESULTS: In group I, the mean age was 57.1 ± 10.1 years; and at the end of 6.7 ± 2.05 months follow up, 14 (70%) of 20 eyes healed completely with a minimal scarring and vascularization. Two patients had persistent epithelial defects, four patients healed incomplete because of deep stromal ulcers in eyes with post-herpes neurotrophic ulcers. In group II, the mean age was 58.7 ± 14.7 years. Seventeen eyes (72.7%) of 22 patients healed completely and there was no recurrence in these patients at the 6.8 ± 3.9 months follow-up period. Two incomplete healed patients had persistent epithelial defects caused by HSV and the other three patients had deep stromal ulcers caused by the abuse of topical anesthetics. The mean epithelialization time was 22.1 ± 8.0 days in group I and 20.0 ± 4.64 days in group II. In group I, best corrected visual acuity improved in 18 of 20 (90%) eyes and 17 of 22 (77.2%) eyes in group II.
CONCLUSIONS: Both autologous serum eye drops and amniotic membrane transplantation are effective for eyes with neurotrophic corneal ulcers because of many epitheliotrophic factors. Also, we observed that multilayered amniotic membrane transplantation is more effective than autologous serum in deep corneal ulcers with postherpes neurotrophic keratitis in our cases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23758337     DOI: 10.3109/08820538.2013.768678

Source DB:  PubMed          Journal:  Semin Ophthalmol        ISSN: 0882-0538            Impact factor:   1.975


  13 in total

1.  Corneal Neuro-Regenerative Effect of Transcutaneous Electrical Stimulation in Rabbit Lamellar Keratectomy Model.

Authors:  Young-Sik Yoo; Sera Park; Pyeonghwa Eun; Young Min Park; Dong Hui Lim; Tae-Young Chung
Journal:  Transl Vis Sci Technol       Date:  2022-10-03       Impact factor: 3.048

2.  Efficacy of treatments for neurotrophic keratopathy: a systematic review and meta-analysis.

Authors:  Sébastien Roumeau; Frédéric Dutheil; Vincent Sapin; Julien S Baker; Stephanie L Watson; Bruno Pereira; Frédéric Chiambaretta; Valentin Navel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-03-07       Impact factor: 3.535

3.  Cutting Edge: Topical Recombinant Nerve Growth Factor for the Treatment of Neurotrophic Keratopathy-Biologicals as a Novel Therapy for Neurotrophic Keratopathy.

Authors:  Pedram Hamrah; Leyla Yavuz Saricay; M Cuneyt Ozmen
Journal:  Cornea       Date:  2022-02-02       Impact factor: 3.152

Review 4.  Diagnosis and management of neurotrophic keratitis.

Authors:  Marta Sacchetti; Alessandro Lambiase
Journal:  Clin Ophthalmol       Date:  2014-03-19

5.  Outcomes of Infectious versus Sterile Perforated Corneal Ulcers after Therapeutic Penetrating Keratoplasty in the United States.

Authors:  Sloan W Rush; Ryan B Rush
Journal:  J Ophthalmol       Date:  2016-12-13       Impact factor: 1.909

Review 6.  Neurotrophic keratitis: current challenges and future prospects.

Authors:  Piera Versura; Giuseppe Giannaccare; Marco Pellegrini; Stefano Sebastiani; Emilio C Campos
Journal:  Eye Brain       Date:  2018-06-28

7.  Long-term clinical outcome and satisfaction survey in patients with neurotrophic keratopathy after treatment with cenegermin eye drops or amniotic membrane transplantation.

Authors:  Marta Sacchetti; Chiara Komaiha; Alice Bruscolini; Giuseppe Maria Albanese; Marco Marenco; Rossella Anna Maria Colabelli Gisoldi; Augusto Pocobelli; Alessandro Lambiase
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-10-11       Impact factor: 3.117

Review 8.  Neurotrophic keratopathy: current challenges and future prospects.

Authors:  Erin NaPier; Matthew Camacho; Timothy F McDevitt; Adam R Sweeney
Journal:  Ann Med       Date:  2022-12       Impact factor: 4.709

Review 9.  Human Serum Eye Drops in Eye Alterations: An Insight and a Critical Analysis.

Authors:  Maria Rosaria De Pascale; Michele Lanza; Linda Sommese; Claudio Napoli
Journal:  J Ophthalmol       Date:  2015-10-04       Impact factor: 1.909

Review 10.  Neurotrophic factors and corneal nerve regeneration.

Authors:  Marta Sacchetti; Alessandro Lambiase
Journal:  Neural Regen Res       Date:  2017-08       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.